Search results
Results from the WOW.Com Content Network
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.
To afford her annual co-pays for Revlimid—$15,000 to $21,000 a year recently, before a new law capping out-of-pocket costs for people on Medicare took effect in 2024—she’s tapped into ...
KFF estimates the average out-of-pocket cost to take the cancer drug Revlimid in 2020 was $6,200, for example. Some 1.4 million Part D enrollees paid more than $2,000 for prescription drugs in ...
When it comes to drug pricing, European regulators are a tough sell. Just ask Johnson & Johnson . The U.K.'s National Institute for Health and Care Excellence, or NICE, took a pass on paying for ...
The years show when a given drug was released onto the pharmaceutical market. This is not a timeline of the development of the antibiotics themselves. 1911 – Arsphenamine , also Salvarsan [ 1 ]
This article is part of a series on the: Culture of the United States; Society; History; Language; People. race and ethnicity; Religion; Arts and literature; Architecture
A healthy payment from big biotech Celgene Corporation helped Epizyme Inc. make one of the biggest moves in biotech so far this year. News that Epizyme Inc.'s EPZ-5676 met its proof of concept ...